AR219955A1 - Procedimiento para preparar derivados de acidos n-alquil (c1-c4)-n'-(2-(5-alquil (c1-c4) -4-imidazililmetiltio)- etil)-amidinsulfinico y sus sales - Google Patents

Procedimiento para preparar derivados de acidos n-alquil (c1-c4)-n'-(2-(5-alquil (c1-c4) -4-imidazililmetiltio)- etil)-amidinsulfinico y sus sales

Info

Publication number
AR219955A1
AR219955A1 AR274409A AR27440978A AR219955A1 AR 219955 A1 AR219955 A1 AR 219955A1 AR 274409 A AR274409 A AR 274409A AR 27440978 A AR27440978 A AR 27440978A AR 219955 A1 AR219955 A1 AR 219955A1
Authority
AR
Argentina
Prior art keywords
alkyl
imidazylyl
amidinsulfinico
methyltio
salts
Prior art date
Application number
AR274409A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of AR219955A1 publication Critical patent/AR219955A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AR274409A 1976-03-11 1978-11-10 Procedimiento para preparar derivados de acidos n-alquil (c1-c4)-n'-(2-(5-alquil (c1-c4) -4-imidazililmetiltio)- etil)-amidinsulfinico y sus sales AR219955A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9750/76A GB1574214A (en) 1976-03-11 1976-03-11 Amidines

Publications (1)

Publication Number Publication Date
AR219955A1 true AR219955A1 (es) 1980-09-30

Family

ID=9878056

Family Applications (2)

Application Number Title Priority Date Filing Date
AR266827A AR218242A1 (es) 1976-03-11 1977-03-11 Procedimiento para la produccion de derivados de acidos n-(2-(imidazolil o tiazolil-metil-tio)-etil)-amidino formico
AR274409A AR219955A1 (es) 1976-03-11 1978-11-10 Procedimiento para preparar derivados de acidos n-alquil (c1-c4)-n'-(2-(5-alquil (c1-c4) -4-imidazililmetiltio)- etil)-amidinsulfinico y sus sales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR266827A AR218242A1 (es) 1976-03-11 1977-03-11 Procedimiento para la produccion de derivados de acidos n-(2-(imidazolil o tiazolil-metil-tio)-etil)-amidino formico

Country Status (34)

Country Link
US (4) US4118502A (es)
JP (1) JPS52136170A (es)
AR (2) AR218242A1 (es)
AT (1) AT358576B (es)
AU (1) AU506146B2 (es)
BE (1) BE852324A (es)
CA (1) CA1075700A (es)
CS (1) CS196352B2 (es)
DD (1) DD128616A5 (es)
DE (1) DE2710326A1 (es)
DK (1) DK96477A (es)
ES (1) ES456735A1 (es)
FI (1) FI770736A (es)
FR (1) FR2343730A1 (es)
GB (1) GB1574214A (es)
GR (1) GR62562B (es)
HU (1) HU176611B (es)
IE (1) IE44786B1 (es)
IL (1) IL51530A (es)
IN (1) IN147036B (es)
IT (1) IT1075494B (es)
LU (1) LU76930A1 (es)
MW (1) MW977A1 (es)
NL (1) NL7702533A (es)
NO (1) NO770854L (es)
NZ (1) NZ183396A (es)
OA (1) OA05595A (es)
PL (1) PL105620B1 (es)
PT (1) PT66255B (es)
RO (1) RO73006A (es)
SE (1) SE7702771L (es)
SU (2) SU814274A3 (es)
ZA (1) ZA771018B (es)
ZM (1) ZM2677A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
EP0006679B1 (en) 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4282213A (en) * 1978-06-06 1981-08-04 Smith Kline & French Laboratories Limited Amidino and guanidino phosphonates
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
IT8020734A0 (it) * 1980-03-18 1980-03-18 Turconi Franco Quadrata (2 aminoetil)-tiometilderivati del 4-metil-5 aperta par.chiusa par. quadrata-imidazolo adattivita' terapeutica.
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
IT1201523B (it) * 1982-05-18 1989-02-02 Angeli Inst Spa Eterociclilfenilfomramidine,processi per la loro preparazione e loro uso farmaceutico
US5399706A (en) * 1993-03-02 1995-03-21 H. B. Fuller Licensing & Financing, Inc. Imidazolidinone diamine and derivatives thereof
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3808336A (en) * 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3734924A (en) * 1970-10-14 1973-05-22 Smith Kline French Lab Carboxamidines
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1421999A (en) 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
US4056620A (en) * 1973-02-08 1977-11-01 Smith Kline & French Laboratories Limited Sulphoxides
US4046907A (en) * 1973-05-17 1977-09-06 Smith Kline & French Laboratories Limited Imidazole alkylaminoethylene compounds
US4025527A (en) * 1973-07-13 1977-05-24 Smith Kline & French Laboratories Limited Certain thiazoles and oxazoles
GB1533380A (en) * 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
US4140783A (en) * 1976-05-24 1979-02-20 Smith Kline & French Laboratories Limited Isothiazole and isoxazole sulphoxides
GB1602458A (en) 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists

Also Published As

Publication number Publication date
RO73006A (ro) 1982-04-12
NL7702533A (nl) 1977-09-13
US4308275A (en) 1981-12-29
GR62562B (en) 1979-05-10
SE7702771L (sv) 1977-09-14
CS196352B2 (en) 1980-03-31
LU76930A1 (es) 1977-07-12
NZ183396A (en) 1979-03-28
SU814274A3 (ru) 1981-03-15
AR218242A1 (es) 1980-05-30
AU506146B2 (en) 1979-12-13
GB1574214A (en) 1980-09-03
IE44786L (en) 1977-09-11
PL196568A1 (pl) 1978-01-16
NO770854L (no) 1977-09-13
AT358576B (de) 1980-09-25
CA1075700A (en) 1980-04-15
FR2343730B1 (es) 1980-01-11
FR2343730A1 (fr) 1977-10-07
IE44786B1 (en) 1982-03-24
AU2315577A (en) 1978-09-14
US4395419A (en) 1983-07-26
IL51530A (en) 1981-03-31
ES456735A1 (es) 1978-06-01
FI770736A (es) 1977-09-12
PL105620B1 (pl) 1979-10-31
US4118502A (en) 1978-10-03
US4438127A (en) 1984-03-20
ZA771018B (en) 1978-01-25
IN147036B (es) 1979-10-27
HU176611B (en) 1981-03-28
ZM2677A1 (en) 1978-07-21
BE852324A (fr) 1977-09-12
IT1075494B (it) 1985-04-22
OA05595A (fr) 1981-04-30
ATA154177A (de) 1980-02-15
SU731896A3 (ru) 1980-04-30
PT66255B (en) 1978-08-07
DD128616A5 (de) 1977-11-30
JPS52136170A (en) 1977-11-14
DE2710326A1 (de) 1977-09-15
DK96477A (da) 1977-09-12
PT66255A (en) 1977-04-01
MW977A1 (en) 1978-08-09

Similar Documents

Publication Publication Date Title
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
AR219955A1 (es) Procedimiento para preparar derivados de acidos n-alquil (c1-c4)-n'-(2-(5-alquil (c1-c4) -4-imidazililmetiltio)- etil)-amidinsulfinico y sus sales
AR221478A1 (es) Procedimiento para preparar compuestos de 4-fenil 6-hidroxialquil(c1-c4)-1,4-dihidropirimidinas y sus sales
AR230280A1 (es) Procedimiento para obtener derivados de carboestirilo y sus sales
AR223069A1 (es) Polieterpoliaminas y sus sales,procedimiento para su preparacion y su empleo
AR225653A1 (es) Un procedimiento para la preparacion de derivados de n-(2-fenil-2-hidroxietil)-1-metil-3-fenil-propilamina y sus sales
AR222658A1 (es) Procedimiento para preparar n-(2-fenil-2-hidroxietil)-1,1,-dimetil-3-(fenil-4-sustituido)-propilamina y sus sales
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
AR224251A1 (es) Procedimiento para la obtencion de derivados de n-(3-fenoxi-2-hidroxi-propil)-n'-(2,4-diozo-pirimidil(6))-alquilendiamina de formula general i
AR228851A1 (es) Procedimiento para preparar 9-hidroxi-9-aminoalquilflourenos y sus sales
AR218454A1 (es) Procedimiento para preparar derivados de 7-beta-amino o 7-beta-(2-oximino-2-furil o 2-fenilacetamido)-3-(sulfoalquil o 3-sulfoaminalquilo o 3-sulfamilalquil-tetrazol-5-il)tiometil 3-cefem-4-carboxilicos y sus sales
AR228586A1 (es) Procedimiento para preparar derivados de 2,3-dihidrobenzofuran-2-ona o croman-2-ona y sus sales farmaceuticamente aceptables
AR226578A1 (es) Procedimiento para preparar tetrapeptidos de try-d-ala-gly-l-(n alfa-substituido)-phe-amida y sus sales
AR218951A1 (es) Procedimiento para obtener derivados de acidos 3-(1-metiltetrazolil-tiometil)-7-glicilamido-1-oxadetia-3-cefem-4-carboxilicos y sus sales
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
AR221352A1 (es) Un procedimiento para preparar derivados de trans-4a-fenil-octahidro-1h2-pirindinas y sus sales
AR224610A1 (es) Procedimiento para obtener derivados,de acidos benzacil-benzimidazol-2-carboxilicos o de 2-hidroximetilo y sus sales
AR222797A1 (es) Procedimiento para preparar compuestos de n-ciano-n'(2-(4-metil-5-imidazolil)-metiltio-etil)-n''alquilnilguanidinas y sus sales
AR217095A1 (es) Procedimiento para preparar derivados de 2-fenil-3-amino-benzo(b)tiofeno y sus sales de adicion de acidos
AR228437A1 (es) Procedimiento para preparar compuestos de 6-fenil-2-oxo-nicotinoilamoxicilina y sus sales
AR228039A1 (es) Procedimiento para obtener derivados de 2-(n'-fenilhidrazino)-1-pirrolina y sus sales
AR226825A1 (es) Procedimiento para preparar derivados de 2-hidroxi-propilaminoalquil guanidinas y sus sales de adicion
AR231720A1 (es) Procedimiento para preparar derivados de 2-(2-(1-alquil-piperidinil)-etil)-carbanilida o tiocarbanilida o benzamidina y sus sales farmaceuticamente aceptables